Jesse Shefferman
Oprichter bij PROTARA THERAPEUTICS, INC.
Vermogen: 3 M $ op 30-04-2024
Actieve functies van Jesse Shefferman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PROTARA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-11-2017 | - |
Algemeen Directeur | 01-11-2017 | - | |
Oprichter | 01-11-2017 | - | |
President | 01-11-2017 | - | |
Financieel Directeur/CFO | 16-07-2022 | 30-01-2023 |
Loopbaan van Jesse Shefferman
Eerdere bekende functies van Jesse Shefferman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-01-2017 | 01-01-2020 |
Algemeen Directeur | 01-01-2017 | 01-01-2020 | |
Oprichter | 01-01-2017 | 01-01-2020 | |
TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-03-2014 | 01-10-2017 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-09-2012 | 01-03-2014 |
Opleiding van Jesse Shefferman
Gordon College | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
PROTARA THERAPEUTICS, INC. | Health Technology |
TRAVERE THERAPEUTICS, INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Health Technology |
- Beurs
- Insiders
- Jesse Shefferman
- Ervaring